Ron Renaud

Ron Renaud serves as the President and CEO of Kailera Therapeutics and holds a board member position at Cardurion Pharmaceuticals. Renaud is also a Senior Advisor in Life Sciences and a Partner at Bain Capital. Additionally, Renaud chairs Upstream Bio and is a board member of Jnana Therapeutics. Academically, Renaud earned an MBA in Finance from the USC Marshall School of Business, completing studies from 1997 to 1999, and holds a BA in Psychology from Saint Anselm College, which was obtained from 1986 to 1990.